Personal Cfo Solutions, LLC Tyme Technologies, Inc. Transaction History

Personal Cfo Solutions, LLC

  • $636 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022
SELL
$0.23 - $0.35 $2,530 - $3,849
-11,000 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$0.6 - $1.04 $300 - $520
-500 Reduced 4.35%
11,000 $7,000
Q3 2021

Nov 18, 2021
SELL
$0.99 - $1.38 $12,759 - $17,785
-12,888 Reduced 52.85%
11,500 $12,000
Q2 2021

Jul 22, 2021
SELL
$1.14 - $1.87 $5,699 - $9,350
-5,000 Reduced 17.01%
24,388 $31,000
Q1 2021

Apr 21, 2021
BUY
$1.34 - $3.53 $39,379 - $103,739
29,388 New
29,388 $52,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Personal Cfo Solutions, LLC Portfolio

Follow Personal Cfo Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email